The Pulmonary Fibrosis Australasian Clinical Trials (PACT) Network is a new comprehensive and integrated clinical research program for Pulmonary Fibrosis (PF) that aims to change PF in Australia. It will provide a powerful springboard for Australia’s world-class PF researchers to drive the search for new evidence to guide future PF care. PACT Network was formed as part of a broader initiative – the Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF). It will act as an advocate and facilitator for clinical trials through its management and support of investigator driven and industry sponsored studies. To find out more, please contact Lung Foundation Australia Sponsor – Galapagos Coming soon – the largest ever Idiopathic Pulmonary Fibrosis (IPF) clinical study to test how effective and safe GLPG1690 (Galapgos NV, Belgium www.glpg.com) is for patients with IPF when used in addition to standard medical treatment.